DDB1 and CUL4 associated factor 13 pseudogene 3Genealiases: []
Q-omics provides the consensus-scored DCAF13P3 profile across patient tissues and cancer cell-line models. DCAF13P3 expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, DCAF13P3 is differentially expressed in 9, with the highest sampling consensus in HNSC. Additionally, DCAF13P3 RNA expression shows 16,456 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight ACC, HNSC, and UVM as cancer lineages where DCAF13P3 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for DCAF13P3 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes DCAF13P3 survival associations across molecular data types. DCAF13P3 RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible DCAF13P3 RNA expression–survival associations across cancer types. High DCAF13P3 expression shows unfavorable associations in ACC, UVM, LUSC and KICH, but favorable associations in COAD and THYM. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for DCAF13P3 RNA expression.
This table summarizes DCAF13P3 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 9. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for DCAF13P3. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. DCAF13P3 shows higher tumor expression in HNSC, LIHC, LUSC, LUAD, COAD and BRCA. The HNSC box plot shows higher DCAF13P3 RNA expression in tumor versus normal tissue (log2 FC = +0.120, t-test p < 0.001).
This table shows molecular features associated with DCAF13P3 in patient tissues and cancer cell lines. In patient samples, DCAF13P3 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set. In cancer cell lines, DCAF13P3 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in SKIN.
